Cargando…

The Efficacy of AgNO3 Nanoparticles Alone and Conjugated with Imipenem for Combating Extensively Drug-Resistant Pseudomonas aeruginosa

INTRODUCTION: The extensive drug-resistant (XDR) Pseudomonas aeruginosa (P. aeruginosa) causes a range of infections with high mortality rate, which inflicts additional costs on treatment. The use of nano-biotechnology-based methods in medicine has opened a new perspective against drug-resistant bac...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahbandeh, Mahsa, Taati Moghadam, Majid, Mirnejad, Reza, Mirkalantari, Shiva, Mirzaei, Mehrnaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518771/
https://www.ncbi.nlm.nih.gov/pubmed/33061358
http://dx.doi.org/10.2147/IJN.S260520
_version_ 1783587449154306048
author Shahbandeh, Mahsa
Taati Moghadam, Majid
Mirnejad, Reza
Mirkalantari, Shiva
Mirzaei, Mehrnaz
author_facet Shahbandeh, Mahsa
Taati Moghadam, Majid
Mirnejad, Reza
Mirkalantari, Shiva
Mirzaei, Mehrnaz
author_sort Shahbandeh, Mahsa
collection PubMed
description INTRODUCTION: The extensive drug-resistant (XDR) Pseudomonas aeruginosa (P. aeruginosa) causes a range of infections with high mortality rate, which inflicts additional costs on treatment. The use of nano-biotechnology-based methods in medicine has opened a new perspective against drug-resistant bacteria. The aim of this study was to evaluate the effectiveness of the AgNO3 nanoparticles alone and conjugated with imipenem (IMI) to combat extensively drug-resistant P. aeruginosa. METHODS: Antibiotic susceptibility was carried out using disc diffusion method. Detection of different resistant genes was performed using standard polymerase chain reaction (PCR). The chemically synthesized AgNO(3) particles were characterized using scanning electron microscope (SEM), dynamic light scattering (DLS) and X-ray diffraction (XRD) methods. Fourier transform infrared spectroscopy (FTIR) was accomplished to confirm the binding of AgNO(3) with IMI. The microdilution broth method was used to obtain minimum inhibitory concentration (MIC) of AgNO(3) and IMI-conjugated AgNO(3). MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay was carried out on L929 cell line to study the cytotoxicity of nanoparticles. The data were analyzed by Eta correlation ratio and chi-square (X(2)) test. RESULTS: Analysis of the antibiotic resistance pattern showed that 12 (24%) isolates were XDR, and MIC values of IMI were between 64 and 128 μg/mL. Frequency of SHV, TEM, CTX M, IMP, VIM, OPR, SIM, SPM, GIM, NDM, VEB, PER, KPC, OXA, intI, intII, and intIII genes were 29 (58%), 26 (52%), 26 (52%), 32 (64%), 23 (46%), 43 (86%), 3 (6%), 6 (12%), 3 (6%), 4 (8%), 7 (14%), 6 (12%), 18 (36%), 4 (8%), 19 (38%), 16 (32%), and 2 (4%), respectively. The XRD, SEM, DLS, and FTIR analysis confirmed the synthesis of AgNO(3) nanoparticles and their conjugation with IMI. The AgNO(3) nanoparticles had antimicrobial activity, and their conjugation with IMI showed enhanced effectiveness against XDR isolates. The synthesized AgNO(3) showed no cytotoxic effects. CONCLUSION: The results suggest that IMI-conjugated AgNO(3) has a strong potency as a powerful antibacterial agent against XDR P. aeruginosa.
format Online
Article
Text
id pubmed-7518771
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-75187712020-10-14 The Efficacy of AgNO3 Nanoparticles Alone and Conjugated with Imipenem for Combating Extensively Drug-Resistant Pseudomonas aeruginosa Shahbandeh, Mahsa Taati Moghadam, Majid Mirnejad, Reza Mirkalantari, Shiva Mirzaei, Mehrnaz Int J Nanomedicine Original Research INTRODUCTION: The extensive drug-resistant (XDR) Pseudomonas aeruginosa (P. aeruginosa) causes a range of infections with high mortality rate, which inflicts additional costs on treatment. The use of nano-biotechnology-based methods in medicine has opened a new perspective against drug-resistant bacteria. The aim of this study was to evaluate the effectiveness of the AgNO3 nanoparticles alone and conjugated with imipenem (IMI) to combat extensively drug-resistant P. aeruginosa. METHODS: Antibiotic susceptibility was carried out using disc diffusion method. Detection of different resistant genes was performed using standard polymerase chain reaction (PCR). The chemically synthesized AgNO(3) particles were characterized using scanning electron microscope (SEM), dynamic light scattering (DLS) and X-ray diffraction (XRD) methods. Fourier transform infrared spectroscopy (FTIR) was accomplished to confirm the binding of AgNO(3) with IMI. The microdilution broth method was used to obtain minimum inhibitory concentration (MIC) of AgNO(3) and IMI-conjugated AgNO(3). MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay was carried out on L929 cell line to study the cytotoxicity of nanoparticles. The data were analyzed by Eta correlation ratio and chi-square (X(2)) test. RESULTS: Analysis of the antibiotic resistance pattern showed that 12 (24%) isolates were XDR, and MIC values of IMI were between 64 and 128 μg/mL. Frequency of SHV, TEM, CTX M, IMP, VIM, OPR, SIM, SPM, GIM, NDM, VEB, PER, KPC, OXA, intI, intII, and intIII genes were 29 (58%), 26 (52%), 26 (52%), 32 (64%), 23 (46%), 43 (86%), 3 (6%), 6 (12%), 3 (6%), 4 (8%), 7 (14%), 6 (12%), 18 (36%), 4 (8%), 19 (38%), 16 (32%), and 2 (4%), respectively. The XRD, SEM, DLS, and FTIR analysis confirmed the synthesis of AgNO(3) nanoparticles and their conjugation with IMI. The AgNO(3) nanoparticles had antimicrobial activity, and their conjugation with IMI showed enhanced effectiveness against XDR isolates. The synthesized AgNO(3) showed no cytotoxic effects. CONCLUSION: The results suggest that IMI-conjugated AgNO(3) has a strong potency as a powerful antibacterial agent against XDR P. aeruginosa. Dove 2020-09-21 /pmc/articles/PMC7518771/ /pubmed/33061358 http://dx.doi.org/10.2147/IJN.S260520 Text en © 2020 Shahbandeh et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Shahbandeh, Mahsa
Taati Moghadam, Majid
Mirnejad, Reza
Mirkalantari, Shiva
Mirzaei, Mehrnaz
The Efficacy of AgNO3 Nanoparticles Alone and Conjugated with Imipenem for Combating Extensively Drug-Resistant Pseudomonas aeruginosa
title The Efficacy of AgNO3 Nanoparticles Alone and Conjugated with Imipenem for Combating Extensively Drug-Resistant Pseudomonas aeruginosa
title_full The Efficacy of AgNO3 Nanoparticles Alone and Conjugated with Imipenem for Combating Extensively Drug-Resistant Pseudomonas aeruginosa
title_fullStr The Efficacy of AgNO3 Nanoparticles Alone and Conjugated with Imipenem for Combating Extensively Drug-Resistant Pseudomonas aeruginosa
title_full_unstemmed The Efficacy of AgNO3 Nanoparticles Alone and Conjugated with Imipenem for Combating Extensively Drug-Resistant Pseudomonas aeruginosa
title_short The Efficacy of AgNO3 Nanoparticles Alone and Conjugated with Imipenem for Combating Extensively Drug-Resistant Pseudomonas aeruginosa
title_sort efficacy of agno3 nanoparticles alone and conjugated with imipenem for combating extensively drug-resistant pseudomonas aeruginosa
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518771/
https://www.ncbi.nlm.nih.gov/pubmed/33061358
http://dx.doi.org/10.2147/IJN.S260520
work_keys_str_mv AT shahbandehmahsa theefficacyofagno3nanoparticlesaloneandconjugatedwithimipenemforcombatingextensivelydrugresistantpseudomonasaeruginosa
AT taatimoghadammajid theefficacyofagno3nanoparticlesaloneandconjugatedwithimipenemforcombatingextensivelydrugresistantpseudomonasaeruginosa
AT mirnejadreza theefficacyofagno3nanoparticlesaloneandconjugatedwithimipenemforcombatingextensivelydrugresistantpseudomonasaeruginosa
AT mirkalantarishiva theefficacyofagno3nanoparticlesaloneandconjugatedwithimipenemforcombatingextensivelydrugresistantpseudomonasaeruginosa
AT mirzaeimehrnaz theefficacyofagno3nanoparticlesaloneandconjugatedwithimipenemforcombatingextensivelydrugresistantpseudomonasaeruginosa
AT shahbandehmahsa efficacyofagno3nanoparticlesaloneandconjugatedwithimipenemforcombatingextensivelydrugresistantpseudomonasaeruginosa
AT taatimoghadammajid efficacyofagno3nanoparticlesaloneandconjugatedwithimipenemforcombatingextensivelydrugresistantpseudomonasaeruginosa
AT mirnejadreza efficacyofagno3nanoparticlesaloneandconjugatedwithimipenemforcombatingextensivelydrugresistantpseudomonasaeruginosa
AT mirkalantarishiva efficacyofagno3nanoparticlesaloneandconjugatedwithimipenemforcombatingextensivelydrugresistantpseudomonasaeruginosa
AT mirzaeimehrnaz efficacyofagno3nanoparticlesaloneandconjugatedwithimipenemforcombatingextensivelydrugresistantpseudomonasaeruginosa